Close

Valeant Pharma (VRX) Unit, Ortho Dermatologics, Granted FDA Acceptance for JEMDEL Plaque Psoriasis Treatment

February 14, 2018 7:17 AM EST Send to a Friend
Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX) today announced that the U.S. Food and Drug Administration ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login